Cannabinoids and cancer: pros and cons of an antitumour strategy.
about
Endocannabinoid system as a regulator of tumor cell malignancy - biological pathways and clinical significanceAn epidemiologic review of marijuana and cancer: an updateCannabinoids as therapeutic agents in cancer: current status and future implicationsWhat we know and do not know about the cannabinoid receptor 2 (CB2)Cannabinoids, endocannabinoids, and cancerCannabinoids as potential new therapy for the treatment of gliomas.Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.FAAH inhibition enhances anandamide mediated anti-tumorigenic effects in non-small cell lung cancer by downregulating the EGF/EGFR pathway.Cannabidiol as potential anticancer drug.Cannabis use and risk of lung cancer: a case-control study.Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids.Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: involvement of CB2Molecular mechanisms involved in the antitumor activity of cannabinoids on gliomas: role for oxidative stress.5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cellsAnti-proliferative effects of anandamide in human hepatocellular carcinoma cells.The cannabinoid CB(2) receptor: a good friend in the gut.Critical appraisal of the potential use of cannabinoids in cancer management.Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon.The endocannabinoid system and sex steroid hormone-dependent cancers.Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?Roles of Eicosanoids in Prostate Cancer.Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor ProgressionUpdate on the endocannabinoid system as an anticancer target.Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo.Proapoptotic effect of endocannabinoids in prostate cancer cellsInvolvement of PAR-4 in cannabinoid-dependent sensitization of osteosarcoma cells to TRAIL-induced apoptosis.Bufalin attenuates cancer-induced pain and bone destruction in a model of bone cancer.Spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system.Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth.Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup.Anti-proliferative, pro-apoptotic and anti-invasive effect of EC/EV system in human osteosarcoma.Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolismEvaluation of anti-invasion effect of cannabinoids on human hepatocarcinoma cells.
P2860
Q26739831-BE0646C1-A36D-43DC-8603-010036894622Q26861353-B56DE56F-68BD-4495-991F-C9472A114A73Q26866298-7ABA0E07-1AB9-4DC9-B78C-8A774FF75920Q27686851-6B29E821-07C8-4D33-8FC3-029D79B39F34Q27694715-A8036537-9B42-4196-A0CB-80FDCB1C33EAQ33310983-8D4CFAC0-BB51-4E9A-8D94-A94DB60C9AFDQ34026054-497A7AF8-6A56-48B6-9ED7-35CF3C9829E7Q34419405-F5A8BC05-943B-4442-A082-65D38A1C0866Q34637516-B46F63FB-A6C9-4ACC-9145-F7CFB22722D4Q34743838-21600140-CF63-4A09-B8C7-FBE48BD8FDD6Q34786464-1DA66C22-018A-4583-8B68-B7611A21D844Q34998169-E15A30E9-3A6A-4025-9D96-132D8FC0F3D1Q35054642-767DF74C-2583-421F-8275-BBF07699C826Q36076364-83C25FB4-7E69-4D28-A1D0-B8AEF290DCDEQ36225947-EF15B565-E148-4B74-BB38-685F1267D24AQ36922349-9221EC5C-1BAE-4C14-83A9-8D194C77D3B8Q37164208-550F58C2-9140-4BB1-95D8-984E75FA6C9CQ37371891-8E6A157F-6699-40FF-A45F-9E3833302541Q37393042-B3831C07-2ADF-4060-9E11-829575E2B338Q37546194-18521BE3-5404-406E-8377-83E3BD6A6282Q37592857-AF0E50B6-7051-40EC-BB10-F503DB485457Q37693612-8F229646-5BD6-45F0-824C-FE016212B5C8Q37829751-8F1B5D85-5CA2-4BB4-AC2F-E2A1173CB04EQ38737351-82CFC7CE-E40F-4CB8-82BB-DB36CB724783Q38918051-4DDEECFE-B10D-4EA1-8C97-1E020B2D5293Q38998620-2FDEF8DC-8B32-47BE-9986-AE489CCD997EQ39150873-513C61D5-05D2-42B0-81A5-A6BF497A479EQ39404976-F1584840-0337-4A00-8499-758257F3CB67Q39574967-B1374007-80EB-4F2C-9616-C744C693C3FFQ41147369-73C9FD56-4704-4A98-90ED-CB374BF52B4CQ41551906-FEEFB240-1E92-41D4-8063-679BCD5AB19BQ42052824-AE1D8310-A372-4653-8679-916B8753181AQ45342027-FC681BB3-9F24-4899-BEA0-D1C8546BDAAA
P2860
Cannabinoids and cancer: pros and cons of an antitumour strategy.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Cannabinoids and cancer: pros and cons of an antitumour strategy.
@ast
Cannabinoids and cancer: pros and cons of an antitumour strategy.
@en
type
label
Cannabinoids and cancer: pros and cons of an antitumour strategy.
@ast
Cannabinoids and cancer: pros and cons of an antitumour strategy.
@en
prefLabel
Cannabinoids and cancer: pros and cons of an antitumour strategy.
@ast
Cannabinoids and cancer: pros and cons of an antitumour strategy.
@en
P2093
P2860
P356
P1476
Cannabinoids and cancer: pros and cons of an antitumour strategy.
@en
P2093
Chiara Laezza
Maurizio Bifulco
Patrizia Gazzerro
Simona Pisanti
P2860
P304
P356
10.1038/SJ.BJP.0706632
P407
P577
2006-05-01T00:00:00Z